Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity
Identifieur interne : 002755 ( Main/Exploration ); précédent : 002754; suivant : 002756Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity
Auteurs : Karina Yusim [États-Unis] ; William Fischer [États-Unis] ; Hyejin Yoon [États-Unis] ; James Thurmond [États-Unis] ; Paul W. Fenimore [États-Unis] ; Georg Lauer [États-Unis] ; Bette Korber [États-Unis] ; Carla Kuiken [États-Unis]Source :
- Journal of general virology [ 0022-1317 ] ; 2010.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Vaccin.
English descriptors
- KwdEn :
Abstract
Immunological control of hepatitis C virus (HCV) is possible and is probably mediated by host T-cell responses, but the genetic diversity of the virus poses a major challenge to vaccine development. We considered monovalent and polyvalent candidates for an HCV vaccine, including natural, consensus and synthetic 'mosaic' sequence cocktails. Mosaic vaccine reagents were designed using a computational approach first applied to and demonstrated experimentally for human immunodeficiency virus type 1 (HIV-Δ). Mosaic proteins resemble natural proteins, but are assembled from fragments of natural sequences via a genetic algorithm and optimized to maximize the coverage of potential T-cell epitopes (all 9-mers) found in natural sequences and to minimize the inclusion of rare 9-mers to avoid vaccine-specific responses. Genotype 1-specific and global vaccine cocktails were evaluated. Among vaccine candidates considered, polyvalent mosaic sequences provided the best coverage of both known and potential epitopes and had the fewest rare epitopes. A global vaccine based on conserved proteins across genotypes may be feasible, as a five-antigen mosaic cocktail provided 90, 77 and 70 % coverage of the Core, NS3 and NS4 proteins, respectively; protein coverage diminished with increased protein variability, dropping to 38% for NS2. For the genotype 1-specific vaccine, the H77 prototype vaccine sequence matched only 50 % of the potential epitopes in the population, whilst a polyprotein three-antigen mosaic cocktail increased potential epitope coverage to 83 %. More than 75 % coverage of all HCV proteins was achieved with a three-antigen mosaic cocktail, suggesting that genotype-specific vaccines could also include the more variable proteins.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000064
- to stream PascalFrancis, to step Curation: 000030
- to stream PascalFrancis, to step Checkpoint: 000065
- to stream Main, to step Merge: 002780
- to stream Main, to step Curation: 002755
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity</title>
<author><name sortKey="Yusim, Karina" sort="Yusim, Karina" uniqKey="Yusim K" first="Karina" last="Yusim">Karina Yusim</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fischer, William" sort="Fischer, William" uniqKey="Fischer W" first="William" last="Fischer">William Fischer</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yoon, Hyejin" sort="Yoon, Hyejin" uniqKey="Yoon H" first="Hyejin" last="Yoon">Hyejin Yoon</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thurmond, James" sort="Thurmond, James" uniqKey="Thurmond J" first="James" last="Thurmond">James Thurmond</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fenimore, Paul W" sort="Fenimore, Paul W" uniqKey="Fenimore P" first="Paul W." last="Fenimore">Paul W. Fenimore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lauer, Georg" sort="Lauer, Georg" uniqKey="Lauer G" first="Georg" last="Lauer">Georg Lauer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School</s1>
<s2>Boston, MA 02114</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Korber, Bette" sort="Korber, Bette" uniqKey="Korber B" first="Bette" last="Korber">Bette Korber</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0421927</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0421927 INIST</idno>
<idno type="RBID">Pascal:10-0421927</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000064</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000030</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000065</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000065</idno>
<idno type="wicri:doubleKey">0022-1317:2010:Yusim K:genotype:and:global</idno>
<idno type="wicri:Area/Main/Merge">002780</idno>
<idno type="wicri:Area/Main/Curation">002755</idno>
<idno type="wicri:Area/Main/Exploration">002755</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity</title>
<author><name sortKey="Yusim, Karina" sort="Yusim, Karina" uniqKey="Yusim K" first="Karina" last="Yusim">Karina Yusim</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fischer, William" sort="Fischer, William" uniqKey="Fischer W" first="William" last="Fischer">William Fischer</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yoon, Hyejin" sort="Yoon, Hyejin" uniqKey="Yoon H" first="Hyejin" last="Yoon">Hyejin Yoon</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thurmond, James" sort="Thurmond, James" uniqKey="Thurmond J" first="James" last="Thurmond">James Thurmond</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fenimore, Paul W" sort="Fenimore, Paul W" uniqKey="Fenimore P" first="Paul W." last="Fenimore">Paul W. Fenimore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lauer, Georg" sort="Lauer, Georg" uniqKey="Lauer G" first="Georg" last="Lauer">Georg Lauer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School</s1>
<s2>Boston, MA 02114</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Korber, Bette" sort="Korber, Bette" uniqKey="Korber B" first="Bette" last="Korber">Bette Korber</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Los Alamos National Laboratory, Theory Division</s1>
<s2>Los Alamos, NM 87545</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of general virology</title>
<title level="j" type="abbreviated">J. gen. virol.</title>
<idno type="ISSN">0022-1317</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of general virology</title>
<title level="j" type="abbreviated">J. gen. virol.</title>
<idno type="ISSN">0022-1317</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Genetic diversity</term>
<term>Genotype</term>
<term>T-Lymphocyte</term>
<term>Vaccine</term>
<term>Viral hepatitis C</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Génotype</term>
<term>Lymphocyte T</term>
<term>Vaccin</term>
<term>Diversité génétique</term>
<term>Hépatite virale C</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Immunological control of hepatitis C virus (HCV) is possible and is probably mediated by host T-cell responses, but the genetic diversity of the virus poses a major challenge to vaccine development. We considered monovalent and polyvalent candidates for an HCV vaccine, including natural, consensus and synthetic 'mosaic' sequence cocktails. Mosaic vaccine reagents were designed using a computational approach first applied to and demonstrated experimentally for human immunodeficiency virus type 1 (HIV-Δ). Mosaic proteins resemble natural proteins, but are assembled from fragments of natural sequences via a genetic algorithm and optimized to maximize the coverage of potential T-cell epitopes (all 9-mers) found in natural sequences and to minimize the inclusion of rare 9-mers to avoid vaccine-specific responses. Genotype 1-specific and global vaccine cocktails were evaluated. Among vaccine candidates considered, polyvalent mosaic sequences provided the best coverage of both known and potential epitopes and had the fewest rare epitopes. A global vaccine based on conserved proteins across genotypes may be feasible, as a five-antigen mosaic cocktail provided 90, 77 and 70 % coverage of the Core, NS3 and NS4 proteins, respectively; protein coverage diminished with increased protein variability, dropping to 38% for NS2. For the genotype 1-specific vaccine, the H77 prototype vaccine sequence matched only 50 % of the potential epitopes in the population, whilst a polyprotein three-antigen mosaic cocktail increased potential epitope coverage to 83 %. More than 75 % coverage of all HCV proteins was achieved with a three-antigen mosaic cocktail, suggesting that genotype-specific vaccines could also include the more variable proteins.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
<li>Nouveau-Mexique</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Nouveau-Mexique"><name sortKey="Yusim, Karina" sort="Yusim, Karina" uniqKey="Yusim K" first="Karina" last="Yusim">Karina Yusim</name>
</region>
<name sortKey="Fenimore, Paul W" sort="Fenimore, Paul W" uniqKey="Fenimore P" first="Paul W." last="Fenimore">Paul W. Fenimore</name>
<name sortKey="Fischer, William" sort="Fischer, William" uniqKey="Fischer W" first="William" last="Fischer">William Fischer</name>
<name sortKey="Korber, Bette" sort="Korber, Bette" uniqKey="Korber B" first="Bette" last="Korber">Bette Korber</name>
<name sortKey="Kuiken, Carla" sort="Kuiken, Carla" uniqKey="Kuiken C" first="Carla" last="Kuiken">Carla Kuiken</name>
<name sortKey="Lauer, Georg" sort="Lauer, Georg" uniqKey="Lauer G" first="Georg" last="Lauer">Georg Lauer</name>
<name sortKey="Thurmond, James" sort="Thurmond, James" uniqKey="Thurmond J" first="James" last="Thurmond">James Thurmond</name>
<name sortKey="Yoon, Hyejin" sort="Yoon, Hyejin" uniqKey="Yoon H" first="Hyejin" last="Yoon">Hyejin Yoon</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002755 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002755 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:10-0421927 |texte= Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity }}
This area was generated with Dilib version V0.6.33. |